Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. (NYSE: BLND) files reports with the U.S. Securities and Exchange Commission as a Delaware corporation in the software publishers industry. On this BLND SEC filings page, Stock Titan aggregates the company’s regulatory disclosures, including current reports on Form 8-K and other periodic filings, and applies AI-powered summaries to help explain their contents in plain language.
Blend’s 8-K filings illustrate the types of material events the company reports to regulators and investors. Recent examples include the announcement of quarterly financial results, where Blend discusses software platform and professional services revenue, GAAP and non-GAAP gross margins, operating income or loss, and key operating metrics. Other 8-K filings cover leadership and executive transitions, such as changes in the Head of Finance and Administration role and related transition agreements, as well as appointments like the Head of Revenue.
Investors can also use this page to locate references to non-GAAP financial measures and the adjustments Blend applies, including stock-based compensation, workforce reduction costs, facilities-related charges, compensation realignment, litigation contingencies, transaction-related costs, software amortization and impairment, executive transition costs, and other items. These details are important for understanding how the company presents measures such as non-GAAP operating income and operating margin alongside GAAP results.
Stock Titan’s interface is designed to make it easier to work through Blend’s SEC disclosures. Users can quickly access quarterly and annual reports when available, review 8-K filings about results of operations, and see filings related to corporate governance or compensation matters. AI-generated highlights help surface the main points of each filing, including financial performance, key agreements, and leadership changes, so readers can navigate Blend’s regulatory history more efficiently.
Blend Labs insider filing: This Form 4 shows transactions by Winnie Ling, Head of Legal and People at Blend Labs (BLND). On 08/20/2025 Ms. Ling was credited with two grants of Restricted Stock Units (RSUs) totaling 81,250 units: 50,000 RSUs reported as vested and 31,250 RSUs newly awarded. A separate entry shows 32,637 shares were withheld to cover taxes in connection with RSU vesting, and a Rule 10b5-1 sale executed on 08/22/2025 disposed of 4,000 shares at $3.50 each. After the transactions the filing reports Ms. Ling beneficially owned 416,631 Class A shares.
Blend Labs insider filing shows grants and tax-withholding on RSUs for Head of Revenue. Brian Kneafsey, an officer and Director-level reporting person, received 75,000 restricted stock units (RSUs) on 08/20/2025 that convert one-for-one into Class A common stock. 33,689 shares were withheld to cover tax obligations at a price of $3.01 per share. Following the transactions, the filing reports 771,598 shares beneficially owned after the RSU grant and 737,909 shares after the withholding. The RSUs vest in equal quarterly installments over two years, subject to continued service.
Blend Labs insider Nima Ghamsari received restricted stock units (RSUs) totaling 500,000 Class A shares on 08/20/2025, comprised of 375,000 and 125,000 awards. Each RSU converts to one share of BLND Class A common stock. The filing shows withholding of 196,751 shares to cover taxes on vesting at a price noted of $3.01 per share, leaving the reporting person with 6,057,300 shares after the transactions. The larger 375,000 RSU grant vests quarterly over four years; the 125,000 RSU grant vests quarterly over two years, both conditioned on continued service. The form was signed by an attorney-in-fact on behalf of the reporting person.
Blend Labs, Inc. (BLND) filed a Form 144 notice for the proposed sale of 4,000 shares of common stock. The sale is to be executed through Charles Schwab & Co., Inc. on the NYSE with an approximate sale date of 08/22/2025 and an aggregate market value reported at $14,000. The shares were acquired on 02/20/2025 by restricted stock lapse from Blend Labs, Inc., with payment described as equity compensation. The filing reports 255,696,747 shares outstanding.
The filing also discloses four sales by Winnie Ling in the past three months: 8,000 shares on 07/03/2025 for $28,000; 4,000 on 07/10/2025 for $14,160; 4,000 on 07/24/2025 for $14,360; and 4,000 on 08/07/2025 for $14,477. The filer certifies no undisclosed material adverse information.
Insiders led by Brian N. Sheth and affiliated entities purchased a total of 683,677 shares of Blend Labs, Inc. (BLND) across three trading days. The purchases occurred on 08/18/2025 (38,585 shares at a weighted average price of $2.9736), 08/19/2025 (292,643 shares at $2.9993 weighted average) and 08/20/2025 (222,449 shares at $2.9601 weighted average). An additional 130,000 Class A shares are reported as held indirectly through a family trust. Following these transactions, the reporting group beneficially owned 3,676,919 Class A shares on an indirect basis. The filings identify Haveli Investments, Haveli Brooks Aggregator, Haveli Investments Software Fund I GP, Whanau Interests LLC, related management entities and Mr. Brian N. Sheth as reporting persons.
Brian Kneafsey, Head of Revenue at Blend Labs, reported the sale of 25,000 shares of Class A common stock on 08/15/2025. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted-average price of $2.8749 per share (range $2.85 to $2.9162). After the reported disposition, the reporting person beneficially owns 696,598 shares directly.
The Form 4 indicates the transaction was routine and executed pursuant to a pre-established plan; the filing was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or other classes of securities are reported in this filing.
Ghamsari Nima, a director and the Head of Blend Labs, sold or transferred 311,886 shares of Class A common stock on 08/14/2025 at a reported price of $2.90 per share. After the transaction, he is reported to beneficially own 5,754,051 shares. The Form 4 explains the shares were transferred to a lender in lieu of payments due under his personal loans. The filing was signed by an attorney-in-fact on 08/18/2025. All information below is taken directly from the Form 4 disclosure.
Blend Labs amendment summary: This Amendment No. 1 to the Schedule 13D updates prior disclosures filed May 6, 2024. Reporting persons (Haveli entities and Brian N. Sheth) report beneficial ownership of 60,388,199 shares of Class A common stock, representing 19.3% of the class on the stated basis. The reported holdings comprise 46,153,845 shares issuable on conversion of Series A preferred, 11,111,112 shares issuable on exercise of warrants and 3,123,242 shares of Class A common stock.
Key change: On August 17, 2025 the Board, at Aggregator's request, approved Aggregator acquiring beneficial ownership of up to 24.9% of outstanding Class A shares (previously restricted to 19.9% under the Investment Agreement). The filing states no transactions by the reporting persons in the past 60 days and adds an amended exhibit (Amended and Restated Annex A).
Blend Labs, Inc. (BLND) Form 3 filed for Ream Jason, who is identified as Head of Finance and Admin and an officer/director of the company. The filing reports the qualifying event date of 08/07/2025 and states that no securities are beneficially owned by the reporting person as of that date. The submission was signed by an attorney-in-fact on 08/15/2025.
Form 144 filing for Blend Labs, Inc. (BLND) reports a proposed sale of 25,000 common shares to be executed through Charles Schwab & Co., Inc. on 08/15/2025 with an aggregate market value of $71,873. The shares were acquired on 02/17/2020 via exercise and hold and fully paid in cash.
The filer previously sold a total of 150,000 shares in six transactions between 06/16/2025 and 07/15/2025, generating aggregate gross proceeds of $503,272. The issuer's reported outstanding shares are 255,696,747, and the planned sale is recorded on the NYSE.
FAQ
What is the current stock price of Blend Labs (BLND)?
What is the market cap of Blend Labs (BLND)?
